Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China and internationally. The company is involved in POCT and plastic product manufacturing; online sales; pharmaceutical manufacturing and sales; and medical testing. It also offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veterinary tests, as well as Biochemistry, chronic disease monitoring systems, and reader and analyzers. In addition, the company offers infectious disease, fertility, fecal occult blood, and vaginal pH tests. Assure Tech (Hangzhou) Co., Ltd. was founded in 2008 and is based in Hangzhou, China.
Frequently asked questions
What sector does Assure Tech Hangzhou Co Ltd (688075) operate in?
Assure Tech Hangzhou Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Assure Tech Hangzhou Co Ltd (688075) current stock price?
As of the latest data, Assure Tech Hangzhou Co Ltd stock price is CN¥30.96, with a previous close of CN¥30.10. Assure Tech Hangzhou Co Ltd gained CN¥0.86 in the last trading session, representing a 2.86% increase.
What is Assure Tech Hangzhou Co Ltd (688075) current market capitalization?
Assure Tech Hangzhou Co Ltd market cap is approximately 3.93 billion.
What is Assure Tech Hangzhou Co Ltd (688075) EBITDA?
Assure Tech Hangzhou Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -9.86 million.
Does Assure Tech Hangzhou Co Ltd (688075) pay dividends?
Yes. Assure Tech Hangzhou Co Ltd pays annual dividends with an annualized yield of 2.58% and an estimated annual payout of CN¥0.80 per share.
When is the next ex-dividend date for Assure Tech Hangzhou Co Ltd (688075)?
The next ex-dividend date is scheduled for July 09, 2027.
What is Assure Tech Hangzhou Co Ltd (688075) beta (volatility) score?
Assure Tech Hangzhou Co Ltd has a beta of 0.593, indicating lower volatility than the overall market.
